Australia
· Delayed Price · Currency is AUD Island Pharmaceuticals Statistics
Total Valuation
ASX:ILA has a market cap or net worth of AUD 47.22 million. The enterprise value is 43.23 million.
| Market Cap | 47.22M |
| Enterprise Value | 43.23M |
Important Dates
The last earnings date was Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:ILA has 236.09 million shares outstanding. The number of shares has increased by 49.16% in one year.
| Current Share Class | 236.09M |
| Shares Outstanding | 236.09M |
| Shares Change (YoY) | +49.16% |
| Shares Change (QoQ) | +44.29% |
| Owned by Insiders (%) | 44.12% |
| Owned by Institutions (%) | 4.70% |
| Float | 108.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 118.23 |
| PB Ratio | 12.14 |
| P/TBV Ratio | 12.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.33 |
| EV / Sales | 108.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.27
| Current Ratio | 10.27 |
| Quick Ratio | 9.85 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -52.73 |
Financial Efficiency
Return on equity (ROE) is -143.22% and return on invested capital (ROIC) is -79.39%.
| Return on Equity (ROE) | -143.22% |
| Return on Assets (ROA) | -65.80% |
| Return on Invested Capital (ROIC) | -79.39% |
| Return on Capital Employed (ROCE) | -82.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +233.33% in the last 52 weeks. The beta is 0.16, so ASX:ILA's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +233.33% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 0.15 |
| Relative Strength Index (RSI) | 50.02 |
| Average Volume (20 Days) | 491,694 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:ILA had revenue of AUD 399,366 and -3.24 million in losses. Loss per share was -0.03.
| Revenue | 399,366 |
| Gross Profit | -1.30M |
| Operating Income | -3.20M |
| Pretax Income | -3.24M |
| Net Income | -3.24M |
| EBITDA | n/a |
| EBIT | -3.20M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 3.99 million in cash and n/a in debt, giving a net cash position of 3.99 million or 0.02 per share.
| Cash & Cash Equivalents | 3.99M |
| Total Debt | n/a |
| Net Cash | 3.99M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 3.89M |
| Book Value Per Share | 0.02 |
| Working Capital | 3.89M |
Cash Flow
| Operating Cash Flow | -2.89M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -800.87% |
| Pretax Margin | -811.95% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:ILA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.16% |
| Shareholder Yield | n/a |
| Earnings Yield | -6.87% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:ILA has an Altman Z-Score of 9.88.
| Altman Z-Score | 9.88 |
| Piotroski F-Score | n/a |